Rising Stars in Malignant Hematology Conference 2024

Saturday, October 5th , 2024  • Toronto, ON

Conference Objectives

The 2024 Rising Stars in Malignant Hematology Conference will serve a foundational role in helping early-in-practice hematologists gain meaningful insight into patient and disease management for hematologic malignancies. This event is geared towards the early-in-practice clinician and will include didactic lectures, complex case discussions, and panel Q&A sessions.

Scientific Steering Committee

The scientific steering committee for the 2024 Rising Stars in Malignant Hematology Conference includes Dr. Peter Anglin and Dr. Alissa Visram.

Alissa Visram, MD

Peter Anglin, MD, MBA, FRCPC

Peter Anglin, MD

Register Today: Spots Are Limited!

Only 40 spots, including limited travel grants, are available for this one-of-a-kind conference and we encourage you to register early.

If you are able to join us, kindly RSVP by registering to the conference using the link below. Registrations will close on August 31st, 2024, or when the conference reaches capacity. As space is limited, we encourage you to RSVP at your earliest convenience if you plan to attend.

Our Sponsors

Key Sponsors

Leaders

Supporters

Single Meeting

Conference Agenda

The 2024 Rising Stars in Malignant Hematology Conference will serve a foundational role in helping early-in-practice hematologists gain meaningful insight into patient and disease management for hematologic malignancies.

Time

Topic

Speaker

9:00 am - 9:10 am

Welcome and Introductions

Alissa Visram

9:10 am - 9:45 am

Personalized Medicine: Understanding the Genetic and Molecular Characteristics of CLL and Tailoring Treatment (Sponsored Breakfast Symposium AstraZeneca Canada)

Philip Kuruvilla

9:45 am - 10:20 am

Approaches to MM: Novel Agents in a Relapse Setting

Darrell White

10:20 am - 10:55 am

Management of AML in 2024: Frontline Therapy

Julie Bergeron

10:55 am - 11:15 am

HEALTH BREAK

ALI

11:15 am - 11:50 am

Updates on the Management of MPN: Current Agents and Approaches to Treatment in First and 2nd Line Therapies

Vikas Gupta

11:50 am - 1:00 pm

CHECKOUT & LUNCH

ALL

1:00 pm - 1:35 pm

Updates on the Management of CLL : Current Agents and Approaches to Treatment in a Relapse Setting

Mona Shafey

1:35 pm - 2:10 pm

Updates on the Management of FL and Aggressive B-cell Lymphoma: Current Agents and Approaches to Treatment in a Relapse Setting

John Kuruvilla

2:10 pm - 2:45 pm

Important Tips & Pearls: Reimbursement, Compassionate Use, Access, Path to Approval, Patient Support Program, Resources for Patients

Darrell White

2:45 pm - 3:20 pm

Attendee Q&A for Conference Faculty

ALL

3:20 pm - 3:30 pm

Meeting Close & Adjournment

Peter Anglin

Subscribe To Canadian Hematology Today

Canadian Hematology Today provides a forum for the clinical community to share real-world experience and the latest best practices in the treatment and management of hematologic disease.

The journal is published thrice yearly in English and French and is circulated to over 1,100 hematology clinicians and researchers across Canada. It features peer-reviewed articles that present robust clinical perspectives and practical insights into disease management.

About Catalytic Health

Founded in 2009, Catalytic Health is one of Canada’s largest medical education agencies and reaches over 50,000 Canadian clinicians a year with its educational programs, services and platforms. Catalytic Health is also the largest independent medical publisher in Canada, one of the largest scientific conference providers, and a leader in innovative events and services for the Life Sciences industry. Learn more about Catalytic Health.

© 2024 All Rights Reserved.